Cite

HARVARD Citation

    Dörner, T. et al. (n.d.). 185 Baricitinib-associated changes in type I interferon gene signature during a 24-week phase 2 clinical SLE trial. Lupus science & medicine. p. A141. [Online]. 
  
Back to record